World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
142
Citations
80792
World Ranking
1559
National Ranking
907

Stephen I. Rennard publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Stephen I. Rennard sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,011 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Stephen I. Rennard D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Stephen I. Rennard sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 142 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Stephen I. Rennard is affiliated with the University of Nebraska Medical Center in the United States. Their research primarily focuses on the field of Medicine, with a particular emphasis on Pulmonary and Respiratory Medicine, contributing to over 170 publications in total.

Their main fields of study include:

  • Pulmonary and Respiratory Medicine
  • Physiology
  • Epidemiology
  • Complementary and alternative medicine
  • Molecular Biology

The primary topics of their research work cover various areas relevant to respiratory health and disease management:

  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory Support and Mechanisms
  • Asthma and respiratory diseases
  • Cardiovascular and exercise physiology
  • Lung Cancer Diagnosis and Treatment
  • Chronic Disease Management Strategies
  • Pediatric health and respiratory diseases

Stephen I. Rennard has contributed to several recent scientific papers, including:

  • "Reconsidering the Utility of Race-Specific Lung Function Prediction Equations," 2021, published in American Journal of Respiratory and Critical Care Medicine
  • "Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease," 2020, published in American Journal of Respiratory and Critical Care Medicine
  • "Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical Activity," 2021, published in Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation
  • "Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease," 2022, published in American Journal of Respiratory and Critical Care Medicine
  • "Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics Outlook," 2023, published in American Journal of Respiratory and Critical Care Medicine

Frequent co-authors who have worked closely with Stephen I. Rennard include:

  • MeiLan K. Han
  • Prescott G. Woodruff
  • David Couper
  • Jeffrey L. Curtis
  • Christopher B. Cooper

Their research articles have often appeared in notable publication venues such as:

  • UNC Libraries
  • American Journal of Respiratory and Critical Care Medicine
  • CHEST Journal
  • Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation
  • Annals of the American Thoracic Society

Best Publications

  • Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

    John R. Hurst;Jørgen Vestbo;Jørgen Vestbo;Antonio Anzueto;Nicholas Locantore

  • A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation

    Douglas E. Jorenby;Scott J. Leischow;Mitchell A. Nides;Stephen I. Rennard

  • Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution.

    S. I. Rennard;G. Basset;D. Lecossier;K. M. O'Donnell

  • Characterisation of COPD heterogeneity in the ECLIPSE cohort

    Àlvar Agustí;Peter Ma Calverley;Bartolome R Celli;Harvey O Coxson

  • Chronic obstructive pulmonary disease phenotypes: the future of COPD.

    Mei Lan K. Han;Alvar Agusti;Peter M. Calverley;Bartolome R. Celli

  • Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation: A Randomized Controlled Trial

    David Gonzales;Stephen I. Rennard;Mitchell Nides;Cheryl Oncken

  • Interstitial Lung Diseases of Unknown Cause: Disorders Characterized by Chronic Inflammation of the Lower Respiratory Tract

    Ronald G. Crystal;Peter B. Bitterman;Stephen I. Rennard;Allan J. Hance

  • Changes in forced expiratory volume in 1 second over time in copd

    Jørgen Vestbo;Jørgen Vestbo;Lisa D. Edwards;Paul D. Scanlon;Julie C. Yates

  • Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts).

    Ronald G. Crystal;Peter B. Bitterman;Stephen I. Rennard;Allan J. Hance

  • Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype.

    Alvar Agustí;Lisa D. Edwards;Stephen I. Rennard;William MacNee

  • A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci

    Sreekumar G. Pillai;Dongliang Ge;Guohua Zhu;Xiangyang Kong

  • Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey

    S Rennard;Marc Decramer;P M A Calverley;N B Pride

  • Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function

    Prescott G. Woodruff;R. Graham Barr;Eugene Bleecker;Stephanie A. Christenson

  • Enzyme-linked immunoassay (ELISA) for connective tissue components

    S.I. Rennard;R. Berg;G.R. Martin;J.M. Foidart

  • Distribution and immunoelectron microscopic localization of laminin, a noncollagenous basement membrane glycoprotein.

    Jean-Michel Foidart;EW Bere;M. Yaar;S. I. Rennard

  • Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.

    J E Gadek;G A Fells;R L Zimmerman;S I Rennard

  • Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells

    Tadashi Mio;Debra Romberger;Austin Bassett Thompson;Richard A. Robbins

  • The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease

    Stephen I. Rennard;Charles Fogarty;Steven Kelsen;William Long

  • Smoking Cessation With Varenicline, a Selective α4β2 Nicotinic Receptor Partial Agonist: Results From a 7-Week, Randomized, Placebo- and Bupropion-Controlled Trial With 1-Year Follow-up

    Mitchell Nides;Cheryl Oncken;David Gonzales;Stephen Rennard

  • Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters.

    Austin B. Thompson;David Daughton;Richard A. Robbins;Mohammed A. Ghafouri

Frequent Co-Authors

Bartolome R. Celli
Bartolome R. Celli Brigham and Women's Hospital
Jørgen Vestbo
Jørgen Vestbo University of Manchester
Debra J. Romberger
Debra J. Romberger University of Nebraska Medical Center
Edwin K. Silverman
Edwin K. Silverman Brigham and Women's Hospital
David A. Lomas
David A. Lomas University College London
Alvar Agusti
Alvar Agusti University of Barcelona
Klaus F. Rabe
Klaus F. Rabe Kiel University
Ruth Tal-Singer
Ruth Tal-Singer GlaxoSmithKline (United Kingdom)
Peter M.A. Calverley
Peter M.A. Calverley University of Liverpool
Emiel F.M. Wouters
Emiel F.M. Wouters Maastricht University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine isn’t limited to traditional medical degrees. Many students choose related fields, such as nursing and healthcare management, which offer robust online learning options. These pathways can fast-track your entry into the healthcare workforce or help you advance your existing medical career.

For those interested in leadership roles, the cheapest dnp programs online provide a pathway to a Doctor of Nursing Practice degree at lower tuition rates. If you’re an RN seeking to boost your credentials, consider enrolling in the cheapest rn to bsn program options for affordable advancement.

Non-nurses looking for a quick transition into advanced practice roles should explore online msn programs for non nurses, which are available in accelerated formats. For entry-level positions, adn programs make starting a nursing career more accessible through flexible admission standards and short study durations.

Whether you’re beginning your journey or ready to specialize, exploring these online medical and nursing degrees can open new doors and diverse career opportunities in the USA’s ever-growing healthcare sector.

Best Scientists Citing Stephen I. Rennard

Trending Scientists

Recently Published Articles